The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia

被引:9
作者
Tsertsvadze, Tengiz [1 ,2 ,3 ]
Sharvadze, Lali [1 ,2 ,3 ]
Chkhartishvili, Nikoloz [2 ]
Dzigua, Lela [2 ]
Karchava, Marine [2 ,3 ]
Gatserelia, Lana [2 ,3 ]
Abutidze, Akaki [2 ,3 ]
Nelson, Kenrad E. [4 ]
机构
[1] Ivane Javakhishvili Tbilisi State Univ, Fac Med, 16 Al Kazbegi Ave, GE-0160 Tbilisi, Georgia
[2] Infect Dis AIDS & Clin Immunol Res Ctr, 16 Al Kazbegi Ave, GE-0160 Tbilisi, Georgia
[3] Georgian French Joint Hepatol Clin Hepa, 16 Al Kazbegi Ave, GE-0160 Tbilisi, Georgia
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room E7638, Baltimore, MD 21205 USA
关键词
HCV; Natural history; Seroconversion; Transitory; SPONTANEOUS VIRAL CLEARANCE; RISK BEHAVIORS; VIREMIA; HIV; DYNAMICS; ABSENCE; AGENTS; RNA;
D O I
10.1186/s12985-016-0478-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: Hepatitis C virus (HCV) infection is a serious health problem in Georgia. Methods: We conducted a prospective study to identify and characterize the natural history of recent HCV infection since very first days of infection. Recent HCV infection was defined as detectable plasma HCV RNA in the absence of anti-HCV antibodies. Results: A total of 7600 HCV seronegative blood donors and 3600 HCV seronegative drug users were screened for recent HCV infection. Among them 7 (0.09 %) blood donors and 10 (0.28 %) drug users tested positive for HCV RNA and were classified as having recent HCV infection. Of these 17 patients 4 (23.5 %) spontaneously cleared the virus by the end of 24 week follow-up. Five clinical forms of recent HCV infection were identified during the follow-up. Four patients had symptomatic disease, including 3 patients with jaundice and other clinical symptoms (2 of them cleared virus) and 1 patient only had other symptoms without jaundice. All symptomatic patients had ALT elevation. Three distinct variants of asymptomatic disease were identified in 13 patients: 9 patients had ALT elevation and none cleared the virus; 2 patients developed chronic disease without ALT elevation; 2 patients cleared virus without anti-HCV seroconversion and without ALT elevation; this form can be described as transitory HCV viremia. Conclusion: Additional studies are needed to define clinical and public health implications of transitory HCV viremia. Our study suggests the need for implementing nucleic acid testing of blood donors and key populations in order to more effectively identify HCV infected persons.
引用
收藏
页数:7
相关论文
共 34 条
[1]  
Coste J, 2005, VOX SANG, V88, P289, DOI 10.1111/j.1423-0410.2005.00636_1.x
[2]   Prospective evaluation of community-acquired acute-phase hepatitis C virus infection [J].
Cox, AL ;
Netski, DM ;
Mosbruger, T ;
Sherman, SG ;
Strathdee, S ;
Ompad, D ;
Vlahov, D ;
Chien, D ;
Shyamala, V ;
Ray, SC ;
Thomas, DL .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (07) :951-958
[3]   Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts [J].
Duggal, Priya ;
Thio, Chloe L. ;
Wojcik, Genevieve L. ;
Goedert, James J. ;
Mangia, Alessandra ;
Latanich, Rachel ;
Kim, Arthur Y. ;
Lauer, Georg M. ;
Chung, Raymond T. ;
Peters, Marion G. ;
Kirk, Gregory D. ;
Mehta, Shruti H. ;
Cox, Andrea L. ;
Khakoo, Salim I. ;
Alric, Laurent ;
Cramp, Matthew E. ;
Donfield, Sharyne M. ;
Edlin, Brian R. ;
Tobler, Leslie H. ;
Busch, Michael P. ;
Alexander, Graeme ;
Rosen, Hugo R. ;
Gao, Xiaojiang ;
Abdel-Hamid, Mohamed ;
Apps, Richard ;
Carrington, Mary ;
Thomas, David L. .
ANNALS OF INTERNAL MEDICINE, 2013, 158 (04) :235-245
[4]   Symptomatic Acute Hepatitis C in Egypt: Diagnosis, Spontaneous Viral Clearance, and Delayed Treatment with 12 Weeks of Pegylated Interferon Alfa-2a [J].
Eldin, Noha Sharaf ;
Ismail, Soheir ;
Mansour, Hala ;
Rekacewicz, Claire ;
El-Houssinie, Moustafa ;
El-Kafrawy, Sherif ;
El Aidi, Saeed ;
Abdel-Hamid, Mohamed ;
Esmat, Gamal ;
Pol, Stanislas ;
Fontanet, Arnaud ;
Mohamed, Mostafa K. .
PLOS ONE, 2008, 3 (12)
[5]   Dynamics of viremia in early hepatitis C virus infection [J].
Glynn, SA ;
Wright, DJ ;
Kleinman, SH ;
Hirschkorn, D ;
Tu, Y ;
Heldebrant, C ;
Smith, R ;
Giachetti, C ;
Gallarda, J ;
Busch, MP .
TRANSFUSION, 2005, 45 (06) :994-1002
[6]   Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine [J].
Grebely, Jason ;
Prins, Maria ;
Hellard, Margaret ;
Cox, Andrea L. ;
Osburn, William O. ;
Lauer, Georg ;
Page, Kimberly ;
Lloyd, Andrew R. ;
Dore, Gregory J. .
LANCET INFECTIOUS DISEASES, 2012, 12 (05) :408-414
[7]   Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection [J].
Hajarizadeh, Behzad ;
Grebely, Jason ;
Applegate, Tanya ;
Matthews, Gail V. ;
Amin, Janaki ;
Petoumenos, Kathy ;
Hellard, Margaret ;
Rawlinson, William ;
Lloyd, Andrew ;
Kaldor, John ;
Dore, Gregory J. .
JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (10) :1722-1729
[8]   Epidemiology and natural history of HCV infection [J].
Hajarizadeh, Behzad ;
Grebely, Jason ;
Dore, Gregory J. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (09) :553-562
[9]   Case definitions for acute hepatitis C virus infection: A systematic review [J].
Hajarizadeh, Behzad ;
Grebely, Jason ;
Dore, Gregory J. .
JOURNAL OF HEPATOLOGY, 2012, 57 (06) :1349-1360
[10]   Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence [J].
Hanafiah, Khayriyyah Mohd ;
Groeger, Justina ;
Flaxman, Abraham D. ;
Wiersma, Steven T. .
HEPATOLOGY, 2013, 57 (04) :1333-1342